Peer Review History
| Original SubmissionOctober 17, 2023 |
|---|
|
PONE-D-23-31139Suicidal ideation and associated factor among pregnant women in Eastern part of Ethiopia.PLOS ONE Dear Dr. Gebremariam, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Feb 16 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Chalachew Kassaw Demoze, Msc Academic Editor PLOS ONE Journal requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for stating the following in the Funding Section of your manuscript: “The whole required (material and humanitarian) cost for this research work was covered by Haramaya University.” We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: “The author(s) received no specific funding for this work.” Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 3. In the online submission form, you indicated that [The datasets used and/or analyzed during the current study are available from the corresponding author upon reasonable request.]. All PLOS journals now require all data underlying the findings described in their manuscript to be freely available to other researchers, either 1. In a public repository, 2. Within the manuscript itself, or 3. Uploaded as supplementary information. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If your data cannot be made publicly available for ethical or legal reasons (e.g., public availability would compromise patient privacy), please explain your reasons on resubmission and your exemption request will be escalated for approval. 4. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript. Additional Editor Comments: Dear editor , I would like to thank you for writing a good paper. But I do have some concerns and corrections 1. Have you done any labratory experiments? for a statement, " those mothers with hyperemesis gravidarum secondary to other medical conditions such as thyroid diseases and liver diseases were excluded from the study after proven investigation." If so, please state the data collection tool. 2. Please rewrite a reliability description (specificity, sensitivity) for each tool you have used to assess the outcome and associated factors.(World Health Organization (WHO) composite international diagnostic interview (CIDI) assessment tool, Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST), Depression, Anxiety, and Stress Scale - 21 (DASS-21) , Abuse Assessment Scale (AAS) and Oslo Social support Scale. 3. It is better to describe some of the clinical variables ( Hypermesisgravidrum and gestational age information) that were taken from their medical card or chart) 4. it is better to correct spelling errors ( at the regression table; medical was written as medical) and number alignment ( center , right and left , look at the regression table) 5. Have you made statistical assumptions? If so, please describe: symptoms of suicidal ideation is also found in depressive symptoms of DASS.) Do you solve this collinearity? , state in detail on data analysis 6. On your exclusion criteria, you did not mention any exclusion of those who have a previous history of mental illness. This might affect your outcome variable if you include how do you treat your data ( there are 3 in your data ) 7. It is better to rewrite the title of the place of study. I mean, it misled a reader as it was conducted in all public hospitals found in eastern Ethiopia. 8. In the discussion , it is better to explain a difference other than data collection tool difference. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Dear authors, Thank you for your contribution to the field. I have had the opportunity to review your manuscript and found it well-written. However, there are some points you need to address to improve the quality of your work, and I have mentioned them section by section as follows: Title and Abstract 1. The title is interesting and it addresses the current public health problem, but you should rewrite it as “Suicidal ideation and its associated factor among pregnant women in the eastern part of Ethiopia: A cross-sectional study.” 2. In the methods section of the abstract, you should incorporate the specific study area and study period. 3.In the result section of the abstract, paraphrase the following sentence to make it easier for the reader: Experiencing intimate partner violence and stress (AOR= 3.46; at 95% CI= = 1.75–6.66) and (AOR = 2.88; at 95% CI = 1.11–7.36) were significantly associated with suicidal ideation among pregnant women. “ 4. Put keywords in ascending order introduction 5. Overall, the introduction is well-written and adheres to the systematic writing of the background (deductive approach), and it maintains coherence between paragraphs. However, try to improve the grammatical errors through proofreading. Methods The methods are clear, and the statistical approaches used in this study are appropriate. I have only three suggestions to improve the paper: 6. The sample size calculation formula does not need to be included in the calculation. The author just needs to convey what formula is used along with the margin of error set to get the required sample size. 7. In lines 102-107, you should specify your study area. In which hospital did you conduct your study? Let us know more about your study hospitals. 8. In lines 120–122, why do you exclude those with hyperemesis gravidarum secondary to other medical conditions such as thyroid diseases and liver diseases after proven investigation? It needs further justification if thyroid diseases and liver diseases have a direct linkage with suicidal ideation; if it is so, don’t forget to cite your reference for your justification. 9. In line 127, why do you use a margin of error of 0.03 instead of 0.05? 10.Line 135-140 Why do you take average monthly attendants since your study period is 2 months? You calculated the k value in the wrong way. Please readjust it. 11. In Line 141, why do you select from the first three since your k value is 2? 12. In lines 143–146, you should provide the questionnaire that was used for your study in a supplementary file and cite it in the method section as a supplemental file. 13. In Line 166 (IPV), you should provide both full words and abbreviations when you use it for the first time. 14. In lines 168–169, move the sentence and merge it under data quality control. 15. In data quality control, did you provide training for data collectors? If so, you should state it in your manuscript. 16. In Line 170-189, move your operational definitions above the data collection instruments and procedures. 17. Cite reference for the operational definitions of pregnant women, hyperemesis gravidarum, Suicidal ideation and sleep quality Results The results are relevant, but you should revise them based on the following comment to improve the manuscript. 18.Line 214, “{26.53” should be replaced by "26.53 years.” 19. Line 215, do you think the word most is suitable for 58.36%? 20. Line 217, delete “with the largest proportion." 21. In Table 1, you should re-categorize the age by using the standard age category. If you have a study participant whose age is less than 18, you should specify it by adding the category <18 years, since it will provide us with good results. 22. It is difficult to assess the average monthly income for your study participants since either they are not civil servants or unless you did a wealth index. 23. Please try to change Table 4 into a pie chart format 24. Lines 260–262, rewrite each factor separately: “ The odds ratio of having suicidal ideation for a pregnant mother with depressive and anxiety symptoms were 2.79 and 3.37 compared to their counterparts (AOR = 2.79; (95% CI= = 1.49–5.23) and AOR = 3.37; (95% CI = 1.69–6.68), respectively.” 25. In Table 5, age less than 20, how do you run the regression for cell value less than 5, which is "3"? It is a critical issue and must be addressed by re-categorizing the age value. 26. In the Table 5 suicidal ideation column, put the suicidal value of yes before no for a better understanding Discussion The discussions are explained well enough and based on the results. But to improve it, you should revise it based on the following comments: 27. In Line 282, try to justify how the tool difference is the possible reason for the variation. Try to justify by raising ideas about each tool and their possibility to increase or decrease their estimation of prevalence. Please try to think beyond tool difference and inclusion criteria 28. Lines 290–292, try to justify how the tool difference is the possible reason for the variation. Try to justify by raising ideas about each tool and their possibility to increase or decrease their estimation of prevalence. Please try to think beyond tool difference and inclusion criteria 29. Line 301, you should specify by stating the specific study area for “This is supported by studies (13–15).” 30. Line 301-303 is not directly linked to your justification. You should better delete it. “A cross-sectional study conducted in the United Kingdom reported that 52.1 percent of participants thought to terminate their pregnancy, and 4.9 percent of them terminated their pregnancy owing to hyperemesis gravidarum.” Strengths and Limitations of the study 31. Line 344, please clarify this sentence:evidence-based laboratory tests Which lab? To assess what? 32. In lines 344–345, it is good to state recall bias and social desirability bias as limitations, but you should better state your effort to reduce those biases in this section. 33.Line 344–346 is a non-sense paragraph; you are expected to paraphrase it “However, recall bias, social desirability, a cross-sectional study design that cannot allow establishing a temporal relationship between suicidal ideation, and significant associated factors were the limitations of the study. Conclusion 34. Your conclusion is aligned with the implication of your study rather than the mere figure of the results and is also drawn from your main finding. I am okay with that. 35. In the recommendation section, why do you only stick with hyperemesis gravidarum since you have many findings? Reviewer #2: 1.It will be more helpful to the readers if the setting where the study was conducted is mentioned in the abstract part. 2.It also makes the research more influential if the research owner gives full feedback on the findings. For example, unwanted pregnancy is a factor for SI, but there is nothing to what should be done 3.It would not be good to use one or two of the references that are out of date 4.The Overview of suicidal ideation among the study population is not organized well based on Global to local contexts . 5.author text document spacing should be double spacing according to the journal guide line ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Eyob Ketema Bogale Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-23-31139R1Suicidal ideation and associated factors among pregnant women attending antenatal care at public hospitals of Harari regional state, Eastern Ethiopia: A cross-sectional studyPLOS ONE Dear Dr. Gebremariam, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Mar 31 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Chalachew Kassaw Demoze, Msc Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments: PLOS one Reviewer comment (Suicidal ideation and associated factors among pregnant women attending antenatal care at public hospitals of Harari regional state, Eastern Ethiopia: A cross-sectional study). 1. On the introduction section 1.1. it is better to change the second reference 1 ( you cited two times ) 2. Discussion 2.1. It is better to revise line number 315-325 , it is better to cite for each measurement of suicidal ideation e.g. EPDS ( cite here a study ) , (SBQ-R) ( cite here), …….. 2.2. It is better to revise line number 330-341, it is better to add citation previous studies ( cite here) , Ethiopia (cite here , in study) and studies done in other countries ( cite here). 2.3. It is better to revise line number 375-378 , It is not advisable to compare with USA studies , please find studies done in low income countries , Asian ….. Finally it is better to revise spelling, grammar and vocabulary corrections on the whole section of a manuscript. [Note: HTML markup is below. Please do not edit.] [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Suicidal ideation and associated factors among pregnant women attending antenatal care at public hospitals of Harari regional state, Eastern Ethiopia: A cross-sectional study PONE-D-23-31139R2 Dear Dr. Gebremariam, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Chalachew Kassaw Demoze, Msc Academic Editor PLOS ONE Additional Editor Comments (optional): Dear author , please revise the following issues: 1. " Various studies have reported that hyperemesis gravidarum can be associated with suicide (14–16). Hyperemesis gravidarum is also one of the predisposing factors for depression, anxiety, and psychological problems, (14-16). "It is better to use a single reference for both . 2. it is better to re-write a discussion citation on both controversial issues "Brazil, 12.55% (72), is included both on inline and lower than the finding." , so it is better to revise it 3. It is better to revise again about the selection of studies done in the USA for discussion , almost you used 4 USA studies for discussion (references 16, 74, 83, 82). It is better to find studies done from comparable socio-economic status, such as in Asia, Latin America, and Africa. 4. It is better to revise grammar, spelling, and consistency throughout the whole body of the manuscript. Reviewers' comments: |
| Formally Accepted |
|
PONE-D-23-31139R2 PLOS ONE Dear Dr. Gebremariam, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Mr Chalachew Kassaw Demoze Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .